Safety study of NMN supplement for DHDDS-CDG
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests whether a supplement called NMN is safe and well-tolerated in children and adults with a rare genetic condition called DHDDS-CDG. NMN may help support cellular energy and protein production, which are affected by this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 4 years old
- You have been diagnosed with DHDDS-CDG (a rare genetic disorder affecting sugar processing) through genetic testing
- You do not have moderate or severe intellectual disability (IQ below 52)
- Your liver and kidney function are adequate (no liver failure, ALT/AST less than 5× normal, eGFR above 30)
- You are not pregnant and not currently in another experimental drug trial
- You are not taking aspirin, metformin, or cholesterol-lowering medications (statins)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures NAD+ (a molecule linked to aging) in healthy adults aged 18-35 or 70+. It will help researchers understand how NAD+ changes with age and if supplements like NR affect it.
This trial tests whether a sustained-release nicotinamide mononucleotide (NMN) supplement can improve immune aging and metabolism in people aged 50-70 who are overweight or have fatty liver, pre-diabetes, or mild type 2 diabetes.
This trial tests whether taking an NMN supplement can help improve the immune system (CD4+ T cells) in people with HIV who have not seen enough immune recovery despite effective antiretroviral therapy.
This study looks at how the body uses NAD+ precursors (nutrients that help cells produce energy) after taking them by mouth. Healthy volunteers will help researchers understand how these supplements are processed, which may guide future treatments for aging and disease.
This trial tests whether a supplement called nicotinamide riboside can help people with a blood disorder called MDS (myelodysplastic syndrome) or early warning signs of it. The supplement is meant to support your bone marrow's ability to make healthy blood cells.
This trial tests whether a supplement called nicotinamide mononucleotide (NMN) can help healthy adults aged 60 to 80 improve their exercise tolerance. You'll take the supplement and do supervised cycling sessions to see if it boosts your stamina.
Hear when a new DHDDS-Congenital Disorder of Glycosylation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.